|
Mobile version
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
Cholera deaths up in Haiti, with worst to come The New York Times Share     The death toll in Haiti's cholera epidemic has reached more than 900, the government reported, as aid groups rushed soap and clean water to a disaster-wracked population to fight the disease. … Several epidemiologists have said the disease has not peaked and will likely worsen and break out in other regions of the country, with United Nations health officials estimating about 270,000 may be sickened in the coming years. More
Electronic pathology system may improve accuracy and efficiency Medscape Medical News Share
With the advent of molecular diagnostics, anatomic oncology pathology reports have become increasingly complex, In addition, workloads for pathologists have increased over the past few years. To ensure accuracy and efficiency in this environment, commercial electronic anatomic pathology systems have been developed, but they are expensive — running between $50,000 and $100,000 or more. Because these systems require new software and hardware, integrating them into a hospital's existing information system can be a challenge. More New risk factor for developing breast cancer: DNA methylation modification to BRCA1 gene Science Daily Share
A research team has identified a new risk factor for developing breast cancer, according to a study published online in the journal Cancer Prevention Research. The risk factor involves a modification (DNA methylation) to the BRCA1 gene. BRCA1 is known for its involvement in breast and ovarian cancer. Women with mutations in this gene, which inactivates its function, are predisposed to these diseases. More Related story: No link found between iron and breast cancer (Reuters) Social networking can help clinical labs recruit more and better medical technologists Dark Daily Share
Everyone in the clinical laboratory testing industry knows that there is an acute shortage of medical technologists and clinical laboratory scientists. But laboratory professionals may be astonished to learn that their MT recruiting programs consistently fail to hire adequate numbers of MTs and CLSs because they nearly always advertise and recruit in the wrong places. More
Study: Adults may not be spreading whooping cough Reuters Share
Children largely spread whooping cough among themselves, so blanket vaccination campaigns targeting teens and adults may be a waste of time, according to a study that looks at how social patterns affect disease transmission. The findings, published in the journal Science, contradict the notion that infected adults are behind outbreaks in California and elsewhere of whooping cough, a contagious disease caused by the bacterium Bordetella pertussis. More Recall of antibiotic susceptibility test cards Medscape Medical News Share
Cards made by bioMérieux, Inc. used to determine susceptibility to the antibiotics piperacillin/tazobactam (Vitek 2 Gram Negative) have been recalled, the U.S. Food and Drug Administration (FDA) announced. A company investigation has confirmed user reports of falsely resistant and falsely susceptible results for Escherichia coli and falsely resistant findings for Klebsiella pneumoniae, according to an alert sent from MedWatch, the FDA's safety information and adverse event reporting program. More Lemongrass essential oil shown to be effective against Candida albicans Infection Control Today Share
Use of essential oils for controlling Candida albicans growth has gained significance due to the resistance acquired by pathogens toward a number of widely used drugs. Tyagi and Malik (2010) sought to test the antifungal activity of selected essential oils against Candida albicans in liquid and vapors phase and to determine the chemical composition and mechanism of action of most potent essential oil. More Gene mutation discovery could affect leukemia treatment AFP via Google News Share
Mutations in a single gene can predict whether leukemia patients will suffer a more severe form of the disease, said a study that could change treatment for the blood cancer. Patients with the gene mutation lived for a median of just over one year, while those without it lived for a median of three and a half years, according to the study in the New England Journal of Medicine. More |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||
